2篇
您的检索式：作者名="Can Yurttas"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Beware of gastric tube in esophagectomy after gastric radiotherapy:A case report显示文摘BACKGROUND Gastric tube formation and pull-up is the most common technique of reconstruction following esophagectomy for esophageal cancer.If previous treatment with radiotherapy for gastric mucosa-associated lymphoid tissue(MALT)-lymphoma restricts suitability of the stomach for anastomosis to the esophagus is unknown.CASE SUMMARY A 57-year-old man underwent sequential chemotherapy and radiotherapy for gastric MALT-lymphoma seven years prior to diagnosis of esophageal adenocarcinoma.Esophagectomy without neoadjuvant treatment was recommended by the multidisciplinary tumor board due to early tumor stage[uT1(sm2)uN+cM0 according to TNM-classification of malignant tumors,8^(th) edition]without lymph node involvement.Minimal invasive esophageal resection with esophagogastrostomy was performed.Due to gastric tube necrosis with anastomotic leakage on the twelfth postoperative day,diverting resection with construction of a cervical salivary fistula was necessary.Rapid recovery facilitated colonic interposition without any complications six months afterwards.CONCLUSION This case report may represent the start for further investigation to know if it is reasonable to refrain from esophagogastrostomy in patients with a long interval between gastric radiotherapy and surgery. | Can Yurttas Doerte Wichmann Cihan Gani Malte N Bongers Stephan Singer Christian Thiel Alfred Koenigsrainer Karolin Thiel | 2022 | World Journal of Clinical Cases2022，10，17： | 0 |
| 2 | Significance of multivisceral resections in oncologic surgery: A systematic review of the literature显示文摘BACKGROUND Multivisceral resections (MVR) are often necessary to reach clear resections margins but are associated with relevant morbidity and mortality. Factors associated with favorable oncologic outcomes and elevated morbidity rates are not clearly defined. AIM To systematically review the literature on oncologic long-term outcomes and morbidity and mortality in cancer surgery a systematic review of the literature was performed. METHODS PubMed was searched for relevant articles (published from 2000 to 2018). Retrieved abstracts were independently screened for relevance and data were extracted from selected studies by two researchers. RESULTS Included were 37 studies with 3112 patients receiving MVR for colorectal cancer (1095 for colon cancer, 1357 for rectal cancer, and in 660 patients origin was not specified). The most common resected organs were the small intestine, bladder and reproductive organs. Median postoperative morbidity rate was 37.9%(range: 7% to 76.6%) and median postoperative mortality rate was 1.3%(range: 0% to 10%). The median conversion rate for laparoscopic MVR was 7.9%(range: 4.5% to 33%). The median blood loss was lower after laparoscopic MVR compared to the open approach (60 mL vs 638 mL). Lymph-node harvest after laparoscopic MVR was comparable. Report on survival rates was heterogeneous, but the 5-year overall-survival rate ranged from 36.7% to 90%, being worst in recurrent rectalcancer patients with a median 5-year overall survival of 23%. R0 -resection, primary disease setting and no lymph-node or lymphovascular involvement were the strongest predictors for long-term survival. The presence of true malignant adhesions was not exclusively associated with poorer prognosis. Included were 16 studies with 1.600 patients receiving MVR for gastric cancer. The rate of morbidity ranged from 11.8% to 59.8%, and the main postoperative complications were pancreatic fistulas and pancreatitis, anastomotic leakage, cardiopulmonary events and post-operative bleedings. Total mortality was between 0% and 13.6% with an R0 -resection achieved in 38.4% to 100% of patients. Patients after R0 resection had 5-year overall survival rates of 24.1% to 37.8%. CONCLUSION MVR provides, in a selected subset of patients, the possibility for good long-term results with acceptable morbidity rates. Unlikelihood of achieving R0 -status, lymphovascular- and lymph -node involvement, recurrent disease setting and the presence of metastatic disease should be regarded as relative contraindications for MVR. | Giorgi Nadiradze Can Yurttas Alfred Konigsrainer Philipp Horvath | 2019 | World Journal of Meta-Analysis2019，7，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员